Tinus Group operates seven production bases across the United States, Canada, Japan, Germany, Hong Kong, Australia, and South Korea. This global footprint supports both international supply chain coverage and localized response capabilities.

All factories are built and operated in strict accordance with GMP and ISO international standards. Depending on local regulations and export requirements, the facilities hold production and export qualifications including NSF GMP, HACCP, ISO22000, and FDA registration, supporting compliant manufacturing across different jurisdictions.

Tinus Group holds a range of internationally recognized certifications covering quality, safety, and specific market requirements. These include NSF GMP, HACCP, ISO22000, HALAL, FDA registration, SGS test reports, TGA certification, ORGANIC certification, and KOSHER certification.

Tinus Group has an R&D team of more than 30 senior scientists and formulation engineers, with team members averaging over 15 years of experience in the dietary supplement and pharmaceutical industries.

Our core technical capability lies in an AI human metabolism simulation system based on the Transformer framework. It supports intelligent formula development and precise trend forecasting, helping shorten development cycles and accelerate product launches. The team completes more than one hundred customized formula development and commercialization projects every year.

Our customers range from startup e-commerce brands and private-label products for major retail chains to multinational pharmaceutical companies.

Due to strict non-disclosure agreements, we cannot disclose specific brand names. Our experience includes health-category sellers in the Amazon Top 100, shelf products for large North American pharmacy chains, and sports nutrition supplement lines for major clubs. To learn about experience relevant to your category, you can schedule a meeting with a product manager.

We provide one-stop manufacturing services for major health product dosage forms, including softgels, hard capsules, tablets, powders, oral liquids, and nutritional gummies.

For specialized dosage forms, such as odorless deep-sea fish oil softgels and vegetarian capsules, we have dedicated patented production lines and processes. We can recommend the most suitable dosage form based on your market needs.

OEM: You provide a mature formula, and we handle production. This is suitable for brands that already own a proprietary formula or have finalized ingredient ratios.

ODM: You provide a product concept, such as “sleep support gummies,” and we handle formula development through finished product delivery. This is suitable for teams without in-house R&D that want to launch quickly.

CDMO: Based on ODM, we become more deeply involved in process optimization and commercial scale-up, helping solve challenges related to difficult dosage forms, stability, and compliant mass production. This is suitable for fast-growing companies with technically complex products moving from lab trials to industrial production.

Yes. ODM formula development is one of our core service strengths.

A standard formula development cycle is 4 to 6 weeks, covering concept design, ingredient screening, sample preparation, stability testing, and pilot scale-up. If the project involves developing test methods for new ingredients, the cycle may extend to 8 weeks.

Yes. We have automatic labeling lines, carton packaging lines, and shrink-wrap packaging lines, supporting the full process from bottle mold development and UV label printing to custom gift box packaging.

We also help brand owners prepare product photography and compliant Supplement Facts or ingredient table materials required for Amazon North America and Europe brand filing, supporting smoother product listing and sales.

We establish and execute a full-process quality control system based on current GMP standards for pharmaceutical and dietary supplement manufacturing. The system includes four key stages:

Incoming raw material testing: 100% inspection to ensure purity and compliance with heavy metal, microbiological, and other standards.

In-process control: Real-time monitoring of key process parameters such as mixing uniformity and disintegration time.

Finished product batch testing: Each batch must pass release testing and receive a COA before shipment.

Stability retention samples: Each finished batch is retained according to requirements and stored until one year after shelf-life expiry, supporting full traceability.

Tinus Group maintains a global Approved Vendor List and works with leading international raw material suppliers and qualified vendors.

Each incoming batch is verified through HPLC or GC testing to confirm identity and content, preventing unverified or non-standard raw materials from entering production.

Yes. We accept and welcome third-party audits.

We maintain long-term cooperation with SGS, Eurofins, and UL, and we accept customer-appointed third-party flight inspections or unannounced audits.

Tinus Group provides a one-stop, end-to-end service process: customer consultation, formula confirmation, precise quotation, contract signing and deposit payment, manufacturing, logistics, delivery, and warehousing.

A dedicated project manager follows each project one-on-one to keep communication transparent and delivery efficient.

Softgels, tablets, and hard capsules: the standard MOQ is 180,000 to 300,000 pieces, depending on process complexity.

Powders and liquids in stick packs or tubes: the MOQ is approximately 100,000 sticks or units.

Nutritional gummies: the MOQ is approximately 1 ton.

The sampling cycle is typically 7 to 15 business days, excluding international logistics.

Sampling fees depend on the specific project.

The standard production lead time is 90 business days, including raw material procurement scheduling and production scheduling.

If raw materials and packaging materials are in stock and no new custom molds are required, expedited orders can be completed in 4 to 6 weeks after production capacity assessment and payment of expedited service fees.

Yes. As an FDA-registered company, we assist brand customers with FDA food facility registration updates, U.S. agent services, and product listing.

For Amazon sellers, we provide ingredient review reports, compliant label templates, child-resistant packaging certification materials, and related documentation to help products pass Amazon hazmat and category reviews.

Tinus Group’s regulatory team is familiar with access requirements in major global markets:

United States: compliance with 21 CFR Part 111 for dietary supplement GMP.

European Union: compliance with EU 1169/2011 labeling regulations and novel food approval requirements.

Southeast Asia: familiarity with the ASEAN Traditional Medicines and Health Supplements framework, supporting registration compliance for Indonesia BPOM, Thailand FDA, Malaysia NPRA, and other member-state requirements.

We screen formulas in advance according to your target market to reduce customs clearance and sales compliance risks.

We provide professional guidance on compliant structure/function claim wording.

We follow DSHEA standards to help ensure Supplement Facts formatting, daily intake information, and health claim wording do not cross FDA drug-claim boundaries, reducing the risk of products being treated as unapproved new drugs.

Formula confidentiality is a core priority for Tinus Group.

We sign legally binding non-disclosure agreements with every customer. Formula documents are stored on internal encrypted servers, and employees are prohibited from sending them to personal email accounts.

We support multiple trade terms, including FOB, CIF, and DDP.

For customs clearance, Tinus Group can provide supporting coordination and help customers connect with reliable customs brokers and logistics service providers to reduce destination-port clearance risks. For DDP orders, we coordinate with local partners to support duty prepayment and last-mile delivery.

Our overseas warehouse network is being actively developed. Once launched, it will further shorten delivery timelines and provide customers with more flexible inventory management and dropshipping options. Please follow official announcements or contact your account manager for the latest updates.

Quality issue handling follows a mutually recognized third-party testing-first principle. If an authoritative organization such as SGS confirms that the issue was caused by the production process, Tinus Group will work with the customer to determine the most reasonable solution based on the nature and severity of the issue. Possible solutions include partial compensation, rework and sorting, replacement production, or full refund. The final solution will follow the quality agreement and purchase contract signed by both parties.

After-sales support includes long-term stability data tracking, consumer complaint response guidance, and formula adjustment support.

Yes. For strategic partners, we provide free support including:

China, North America, and Europe hot-category data analysis reports based on SPINS and Amazon sales data.

Product selling-point refinement and sales team training materials.

You can click “Get a Quote” in the upper-right corner of the website or email info@tinusgroup.com. We will respond within 12 hours.

Factory visits: We welcome customers to view factory production sites through real-time remote video after signing a non-disclosure agreement. For an on-site visit, please make an appointment at least 2 weeks in advance so we can arrange technical translation and reception support.